366 related articles for article (PubMed ID: 32092317)
21. Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer.
Akin Duman T; Ozturk FN
J Hum Genet; 2023 Jul; 68(7):485-490. PubMed ID: 36864289
[TBL] [Abstract][Full Text] [Related]
22. Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.
Rudnicka H; Debniak T; Cybulski C; Huzarski T; Gronwald J; Lubinski J; Gorski B
Mol Biol Rep; 2013 Dec; 40(12):6619-23. PubMed ID: 24065545
[TBL] [Abstract][Full Text] [Related]
23. Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer.
de la Hoya M; Gutiérrez-Enríquez S; Velasco E; Osorio A; Sanchez de Abajo A; Vega A; Salazar R; Esteban E; Llort G; Gonzalez-Sarmiento R; Carracedo A; Benítez J; Miner C; Díez O; Díaz-Rubio E; Caldes T
Clin Chem; 2006 Aug; 52(8):1480-5. PubMed ID: 16793929
[TBL] [Abstract][Full Text] [Related]
24. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
25. Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea.
Kim DH; Chae H; Jo I; Yoo J; Lee H; Jang W; Park J; Lee GD; Jeon DS; Lee KH; Hur SY; Chae BJ; Song BJ; Kim M; Kim Y
BMC Med Genet; 2017 Mar; 18(1):38. PubMed ID: 28351343
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel
Nicolussi A; Belardinilli F; Silvestri V; Mahdavian Y; Valentini V; D'Inzeo S; Petroni M; Zani M; Ferraro S; Di Giulio S; Fabretti F; Fratini B; Gradilone A; Ottini L; Giannini G; Coppa A; Capalbo C
PeerJ; 2019; 7():e7972. PubMed ID: 31741787
[TBL] [Abstract][Full Text] [Related]
27. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
[TBL] [Abstract][Full Text] [Related]
28. A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
Scaglione GL; Concolino P; De Bonis M; De Paolis E; Minucci A; Ferrandina G; Scambia G; Capoluongo E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570666
[No Abstract] [Full Text] [Related]
29. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Mafficini A; Simbolo M; Parisi A; Rusev B; Luchini C; Cataldo I; Piazzola E; Sperandio N; Turri G; Franchi M; Tortora G; Bovo C; Lawlor RT; Scarpa A
Oncotarget; 2016 Jan; 7(2):1076-83. PubMed ID: 26745875
[TBL] [Abstract][Full Text] [Related]
30. Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.
Rizza R; Hackmann K; Paris I; Minucci A; De Leo R; Schrock E; Urbani A; Capoluongo E; Gelli G; Concolino P
Mol Diagn Ther; 2019 Feb; 23(1):121-126. PubMed ID: 30506513
[TBL] [Abstract][Full Text] [Related]
31. Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing.
Sim WC; Lee CY; Richards R; Bettens K; Mottier V; Goh LL
Exp Mol Pathol; 2020 Oct; 116():104483. PubMed ID: 32531196
[TBL] [Abstract][Full Text] [Related]
32. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
McVeigh TP; Cody N; Carroll C; Duff M; Farrell M; Bradley L; Gallagher D; McDevitt T; Green AJ
Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
[TBL] [Abstract][Full Text] [Related]
33. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
Enyedi MZ; Jaksa G; Pintér L; Sükösd F; Gyuris Z; Hajdu A; Határvölgyi E; Priskin K; Haracska L
Oncotarget; 2016 Sep; 7(38):61845-61859. PubMed ID: 27533253
[TBL] [Abstract][Full Text] [Related]
35. Next Generation Sequencing is a Reliable Tool for Detecting BRCA1/2 Mutations, Including Large Genomic Rearrangements.
Lee JH; Ryoo NH; Ha JS; Park S; Kim KB; Kang SH; Kim DH
Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142179
[TBL] [Abstract][Full Text] [Related]
36. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
38. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive BRCA1/2 NGS pipeline for an immediate Copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosis.
Concolino P; Rizza R; Mignone F; Costella A; Guarino D; Carboni I; Capoluongo E; Santonocito C; Urbani A; Minucci A
Clin Chim Acta; 2018 May; 480():173-179. PubMed ID: 29458049
[No Abstract] [Full Text] [Related]
40. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
Maistro S; Teixeira N; Encinas G; Katayama ML; Niewiadonski VD; Cabral LG; Ribeiro RM; Gaburo Junior N; de Gouvêa AC; Carraro DM; Sabino EC; Diz MD; Chammas R; de Bock GH; Folgueira MA
BMC Cancer; 2016 Dec; 16(1):934. PubMed ID: 27914478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]